Search research articles
Contact Us
Filters
Showing results (251-260 of 282) with videos related to
Page
of 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2010
External-beam accelerated partial breast irradiation using multiple proton beam configurations
Xiaochun Wang, Richard A Amos, Xiaodong Zhang, et al.
Practical Radiation Oncology
|
March 26, 2015
Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique
Eric A Strom, Richard A Amos, Simona F Shaitelman, et al.
Blood Advances
|
December 21, 2022
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial
G A Amos Burke, Luciana Vinti, Edita Kabickova, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2013
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer
Thomas J Pugh, Mark F Munsell, Seungtaek Choi, et al.
Nature Communications
|
January 13, 2016
Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress
Tim I M Malcolm, Patrick Villarese, Camilla J Fairbairn, et al.
The Lancet. Haematology
|
April 24, 2023
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
Sarah Alexander, Anne Aupérin, Simon Bomken, et al.
Biotechnology for Biofuels
|
January 27, 2018
Working towards recalcitrance mechanisms: increased xylan and homogalacturonan production by overexpression of <i>GAlactUronosylTransferase12</i> (<i>GAUT12</i>) causes increased recalcitrance and decreased growth in <i>Populus</i>
Ajaya K Biswal, Melani A Atmodjo, Sivakumar Pattathil, et al.
The New England Journal of Medicine
|
June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Véronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.
Leukemia
|
October 22, 2021
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Alexander M Newman, Masood Zaka, Peixun Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2021
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial
G A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 282) with videos related to
Sort By:
Page
of 29
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2010
External-beam accelerated partial breast irradiation using multiple proton beam configurations
Xiaochun Wang, Richard A Amos, Xiaodong Zhang, et al.
Practical Radiation Oncology
|
March 26, 2015
Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique
Eric A Strom, Richard A Amos, Simona F Shaitelman, et al.
Blood Advances
|
December 21, 2022
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial
G A Amos Burke, Luciana Vinti, Edita Kabickova, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2013
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer
Thomas J Pugh, Mark F Munsell, Seungtaek Choi, et al.
Nature Communications
|
January 13, 2016
Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress
Tim I M Malcolm, Patrick Villarese, Camilla J Fairbairn, et al.
The Lancet. Haematology
|
April 24, 2023
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
Sarah Alexander, Anne Aupérin, Simon Bomken, et al.
Biotechnology for Biofuels
|
January 27, 2018
Working towards recalcitrance mechanisms: increased xylan and homogalacturonan production by overexpression of <i>GAlactUronosylTransferase12</i> (<i>GAUT12</i>) causes increased recalcitrance and decreased growth in <i>Populus</i>
Ajaya K Biswal, Melani A Atmodjo, Sivakumar Pattathil, et al.
The New England Journal of Medicine
|
June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Véronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.
Leukemia
|
October 22, 2021
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Alexander M Newman, Masood Zaka, Peixun Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2021
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial
G A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.
Page
of 29